[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,231
  • Shares Outstanding, K 3,090
  • Annual Sales, $ 5,310 K
  • Annual Income, $ -4,970 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.28
  • Price/Sales 1.40
  • Price/Cash Flow N/A
  • Price/Book 2.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) +832,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.05 +14.15%
on 04/16/26
2.44 -3.92%
on 05/14/26
+0.23 (+10.90%)
since 04/15/26
3-Month
1.87 +25.38%
on 03/06/26
2.44 -3.92%
on 05/14/26
+0.05 (+2.18%)
since 02/13/26
52-Week
1.87 +25.38%
on 03/06/26
4.60 -49.13%
on 08/14/25
-1.33 (-36.26%)
since 05/15/25

Most Recent Stories

More News
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

IRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an...

BMRA : 2.34 (-2.90%)
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway

The Medicare Administrative Contractor (MAC) responsible for processing inFoods® IBS claims has confirmed to Biomerica’s certified laboratory partner that the test will be reviewed on an individual,...

BMRA : 2.34 (-2.90%)
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

— Represents Biomerica’s First Commercial Entry into the Canadian Market for its Precision, Diagnostic-Guided Therapy  — Canada Has One of the Highest IBS Prevalence Rates in the World — an...

BMRA : 2.34 (-2.90%)
Biomerica Reports Third Quarter Fiscal 2026 Financial Results

IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or the “Company”) a global provider of advanced medical diagnostic and therapeutic products today...

BMRA : 2.34 (-2.90%)
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

First Commercial Order by Large Lab Chain: Biomerica has received its first commercial order for Hp Detect™, from one of the largest clinical laboratory chains operating across Europe. Strategic Account:...

BMRA : 2.34 (-2.90%)
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

UK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great Britain Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic...

BMRA : 2.34 (-2.90%)
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

Key Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent...

HSIC : 72.72 (+0.15%)
BMRA : 2.34 (-2.90%)
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution

Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare Market Simple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes ...

BMRA : 2.34 (-2.90%)
Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA),...

BMRA : 2.34 (-2.90%)
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure. The $300 rate will apply to claims approved and paid...

BMRA : 2.34 (-2.90%)

Business Summary

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include...

See More

Key Turning Points

3rd Resistance Point 2.59
2nd Resistance Point 2.51
1st Resistance Point 2.42
Last Price 2.34
1st Support Level 2.25
2nd Support Level 2.17
3rd Support Level 2.08

See More

52-Week High 4.60
Fibonacci 61.8% 3.56
Fibonacci 50% 3.23
Fibonacci 38.2% 2.91
Last Price 2.34
52-Week Low 1.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.